This section contains press releases and other materials from third parties (including paid content). The Globe and Mail has not reviewed this content. Please see disclaimer.
Stocks in play: HLS Therapeutics Inc.
Has filed with the Toronto Stock Exchange, and the TSX has accepted, the Company's notice of intention regarding a Normal Course Issuer Bid for its issued and outstanding common shares. HLS Therapeutics Inc. shares T.HLS are trading up $0.12 at $4.59.
